|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 389K 368K 334K 625K 42.27M 632K 4.41M 1.7M 21.58M 1.65M 1.62M 69.46M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.89M 2.74M 2.48M 4.66M 315M 4.7M 32.85M 12.66M 161M 12.31M 12.05M 517M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 04/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 31/07/2025 |
| Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 19/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 30/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/01/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 28/01/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.3M -14.47M -13.13M -24.61M -1.66B -24.85M -174M -66.91M -849M -65.09M -63.67M -2.73B | -11.14M -9.83M -9.3M -8.43M -15.81M -1.07B -15.97M -112M -42.99M -546M -41.82M -40.91M -1.76B |
| Net Debt | 2.89M 2.55M 2.41M 2.19M 4.1M 277M 4.14M 28.92M 11.15M 141M 10.84M 10.6M 455M | 2.84M 2.51M 2.37M 2.15M 4.03M 272M 4.07M 28.44M 10.96M 139M 10.66M 10.43M 448M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















